Food News and Research

RSS

U.S. troops serving overseas to be tested for H1N1 infection

The U.S. Food and Drug Administration today announced it has issued an Emergency Use Authorization (EUA) that allows a 2009 H1N1 influenza virus test to be used to detect the virus in troops serving overseas.

26 Aug 2009

U.S. Patent Office’s patent issuance provides extensive protection to BDSI's drug delivery technology platforms

BioDelivery Sciences International, Inc. today announced the issuance of United States Patent 7,579,019, which will provide additional patent exclusivity for both ONSOLIS and BDSI’s BEMA drug delivery technology platform until at least 2019.

26 Aug 2009

Hiberix receives accelerated approval from FDA to overcome nationwide shortage

The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.

26 Aug 2009

PuriCore reduces operating expenses by 14% in H1 2009 when compared with H1 2008

PuriCore (LSE: PURI), the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, today announces its interim results for the six months ending June 30, 2009. An H1 2009 Operating and Financial Report and detailed financial results are available here at PuriCore’s website.

25 Aug 2009

Delcath Systems enrolls 85 patients for its pivotal Phase III Metastatic Melanoma Trial

Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that it has exceeded 90% enrollment reaching 85 patients for its pivotal Phase III Metastatic Melanoma Trial.

25 Aug 2009

The SaniGuard dry-on-contact sanitising spray is launched by MisterSterile.com

A sanitising spray that kills 99.99% of Viruses, Bacteria and Germs is now available for purchase in the UK. The SaniGuard wipes, spray and fogger products were invented by David Morgan, president of DEM Technology in the United States. After patenting the product he was awarded EPA registration for its use on food contact surfaces in 1996.

25 Aug 2009

Study finds presence of diethylene glycol and nitrosamines in e-cigarettes

A recent laboratory study performed at the request of the Food and Drug Administration revealed ingredients in e-cigarettes that skeptics suspected all along. The minuscule presence of diethylene glycol, an ingredient that is found in antifreeze and certain levels of nitrosamines, were found in some cartridges.

25 Aug 2009

Garden Of Life introduces dietary supplement capsule that minimizes varicose and spider veins

For years, millions of women tried everything from heavy leg make up to dark pantyhose to cover up unsightly varicose and spider veins. Now there's a better way to reduce the appearance of unwanted veins with Garden of Life's (www.gardenoflife.com) Lovely Legs(TM), the only dietary supplement backed by extensive human clinical studies and millions of happy European women.

25 Aug 2009

Genome BC's research projects to determine efficient methods of liberating fermentable sugars from dead pine

In order to reduce the Province's greenhouse gas emissions, the BC Bioenergy Strategy is calling for greatly increased production of renewable biofuels such as ethanol, from biomass grown in BC. Two new research projects, largely funded by Genome BC, will help to answer these questions and unlock the valuable green energy found within BC's forests.

25 Aug 2009

Seattle Genetics completes enrollment of its pivotal clinical trial of brentuximab vedotin

Seattle Genetics, Inc. today announced that it has completed enrollment of its pivotal clinical trial of brentuximab vedotin (SGN-35) for relapsed and refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30 utilizing the company’s proprietary ADC technology.

25 Aug 2009

FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the Food and Drug Administration (FDA) has accepted for filing and designated for Priority Review the Company’s New Drug Application (NDA) for rifaximin tablets 550 mg for the maintenance of remission of hepatic encephalopathy (HE). Additionally, the FDA has informed the Company of its plan to schedule an Advisory Committee meeting in late February 2010 to discuss the application.

25 Aug 2009

A new therapy for treating gastro-oesophageal reflux in babies

20% of parents seek medical help because of the frequent regurgitation (spitting up food) of their baby and the accompanying discomfort (crying). Reputed medical journal "Archives of Disease in Childhood" of the "British Medical Journal" group recently published the results of the clinical research project that began at the end of 2006 in the Children's gastroenterology department of the Brussels University Hospital.

25 Aug 2009

Nutra Pharma submits final packaging and labeling for Cobroxin drug for FDA approval

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully submitted final packaging and labeling to the Food and Drug Administration (FDA) to begin selling Cobroxin, an over-the-counter (OTC) treatment for stage 2 (moderate to severe) chronic pain.

25 Aug 2009

Field and DNA studies reveal that marine reserves aid in shark conservation measures

A long-term field and DNA study by the Institute for Ocean Conservation Science at Stony Brook University, University of Miami, Field Museum of Chicago and others has shown that young lemon sharks born at the Bimini islands, Bahamas, tend to stay near their coastal birthplace for many years.

25 Aug 2009

Smokers may exacerbate malnutrition in developing countries, study finds

The ANI24/Times of India examines the results of a recent study that found smokers in rural Indonesia tend to compromise their family food budgets in order to support their habit.

25 Aug 2009

FDA issues final approval for manufacturing and marketing Ranbaxy's Glycopyrrolate tablets

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Glycopyrrolate Tablets USP, 1 mg and 2 mg.

25 Aug 2009

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

UCB and sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved XYZAL(R) (levocetirizine dihydrochloride) for children age six months and older for the relief of symptoms of perennial allergic rhinitis (indoor allergies) and chronic idiopathic urticaria (chronic hives) and for children age two years and older for symptoms of seasonal allergic rhinitis (outdoor allergies).

25 Aug 2009

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ: APCVZ), announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market penicillin G potassium for Injection, USP, in two dosage strengths. Penicillin G is therapeutically equivalent to the reference drug PfizerPen™ G, which is marketed by the innovator Pfizer, Inc.

25 Aug 2009

FDA approves new model of ZOLL's LifeVest wearable defibrillator

ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has received approval from the U.S. Food and Drug Administration (FDA) to market and sell a new model of the LifeVest® wearable defibrillator.

25 Aug 2009

Low-carbohydrate and high-protein diet increases the risk for atherosclerosis and impaired blood vessels

Even as low-carbohydrate/high-protein diets have proven successful at helping individuals rapidly lose weight, little is known about the diets' long-term effects on vascular health.

25 Aug 2009

Food News and Research

U.S. troops serving overseas to be tested for H1N1 infection

U.S. Patent Office’s patent issuance provides extensive protection to BDSI's drug delivery technology platforms

Hiberix receives accelerated approval from FDA to overcome nationwide shortage

PuriCore reduces operating expenses by 14% in H1 2009 when compared with H1 2008

Delcath Systems enrolls 85 patients for its pivotal Phase III Metastatic Melanoma Trial

The SaniGuard dry-on-contact sanitising spray is launched by MisterSterile.com

Study finds presence of diethylene glycol and nitrosamines in e-cigarettes

Garden Of Life introduces dietary supplement capsule that minimizes varicose and spider veins

Genome BC's research projects to determine efficient methods of liberating fermentable sugars from dead pine

Seattle Genetics completes enrollment of its pivotal clinical trial of brentuximab vedotin

FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets

A new therapy for treating gastro-oesophageal reflux in babies

Nutra Pharma submits final packaging and labeling for Cobroxin drug for FDA approval

Field and DNA studies reveal that marine reserves aid in shark conservation measures

Smokers may exacerbate malnutrition in developing countries, study finds

FDA issues final approval for manufacturing and marketing Ranbaxy's Glycopyrrolate tablets

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

FDA approves new model of ZOLL's LifeVest wearable defibrillator

Low-carbohydrate and high-protein diet increases the risk for atherosclerosis and impaired blood vessels

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News